Profile
| Metric | Value |
|---|---|
| Full Name | Cidara Therapeutics, Inc. |
| Ticker | NASDAQ: CDTX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | cidara.com |
| Employees | 38 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $221.38 | |
| Price, 1D Change | - | |
| $7B | ||
| - | ||
| - | ||
| 0.92 | ||
| $1M | ||
| Revenue, 1Y Change | -94.52% | |
| -$26.46 | ||
| EPS, 1Y Change | -404.45% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:20 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$26.46 | ||
| EPS Estimate | -$8.68 | |
| EPS Est. Change | +67.20% | |
| $1.28M | ||
| Revenue Estimate | - | |
| Revenue Est. Change | - | |
| Current Price | $221.38 | |
| Price Target | - | $221.50 |
| Price Tgt. Change | - | +0.05% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.31 | -$5.25 | -1,592.19% | |
| -$22.94 | -$26.46 | -15.38% | |
| -$8.68 | N/A | +67.20% | |
| -$7.21 | N/A | +72.75% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $57.85M | $23.28M | -59.75% | |
| $6.03M | $1.28M | -78.85% | |
| - | N/A | - | |
| $11.80M | N/A | +825.49% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $221.38 | |
| $85.66 | ||
| SMA 200 vs Price | -61.30% | |
| $190.09 | ||
| SMA 50 vs Price | -14.14% | |
| 0.92 | ||
| $1.39 | ||
| 84.20 | ||
| 1.53% | ||
| 171.12% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $1.28M | ||
| -$26.46 | ||
| $1.04M | ||
| 81.73% | ||
| -$176.10M | ||
| -7,154.43% | ||
| -$170.29M | ||
| -13.36% | ||
| -$175.87M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.02 | ||
| 4.25 | ||
| 4.25 | ||
| - | ||
| - | ||
| 74.15 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 16.48 | ||
| -40.92 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $163.31M | ||
| $189.83M | ||
| $215.58M | ||
| $210.74M | ||
| $52.27M | ||
| $49.55M | ||
| $3.58M | ||
| $1.64M | ||
| $3.61M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $177.38M | ||
| $177.38M | ||
| $233.00K | ||
| $20.62M | ||
| $233.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$176.53M | ||
| -$129.00K | ||
| $337.06M | ||
| $129.00K | ||
| -$176.66M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Guggenheim | → | |
| Needham | → | |
| HC Wainwright & Co. | → | |
| RBC Capital | → | |
| Needham | → | |
| HC Wainwright & Co. | → | |
| Morgan Stanley | ||
| JP Morgan | ||
| WBB Securities | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with CDTX
FAQ
What is the ticker symbol for Cidara Therapeutics, Inc.?
The ticker symbol for Cidara Therapeutics, Inc. is NASDAQ:CDTX
Does Cidara Therapeutics, Inc. pay dividends?
No, Cidara Therapeutics, Inc. does not pay dividends
What sector is Cidara Therapeutics, Inc. in?
Cidara Therapeutics, Inc. is in the Healthcare sector
What industry is Cidara Therapeutics, Inc. in?
Cidara Therapeutics, Inc. is in the Biotechnology industry
What country is Cidara Therapeutics, Inc. based in?
Cidara Therapeutics, Inc. is headquartered in United States
When did Cidara Therapeutics, Inc. go public?
Cidara Therapeutics, Inc. initial public offering (IPO) was on April 15, 2015
Is Cidara Therapeutics, Inc. in the S&P 500?
No, Cidara Therapeutics, Inc. is not included in the S&P 500 index
Is Cidara Therapeutics, Inc. in the NASDAQ 100?
No, Cidara Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Cidara Therapeutics, Inc. in the Dow Jones?
No, Cidara Therapeutics, Inc. is not included in the Dow Jones index
When was Cidara Therapeutics, Inc. last earnings report?
Cidara Therapeutics, Inc.'s most recent earnings report was on November 6, 2025
When does Cidara Therapeutics, Inc. report earnings?
The next expected earnings date for Cidara Therapeutics, Inc. is March 5, 2026
Data Sources & References
- CDTX Official Website www.cidara.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1610618/000161061825000096/0001610618-25-000096-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1610618/000161061825000017/0001610618-25-000017-index.htm
- CDTX Profile on Yahoo Finance finance.yahoo.com/quote/CDTX
- CDTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cdtx